Clinical Context Hypoglycemia—blood glucose falling below normal levels—triggers a coordinated counterregulatory response designed to restore euglycemia. This defense system involves…
Browsing: PICO
Summary: In patients with type 2 diabetes, stratified by ApoE genotype (E2/E3, E3/E3, E3/E4, and E4/E4 carriers), flaxseed oil supplementation…
Clinical Context Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) affects up to 70-80% of patients with type 2 diabetes,…
Clinical Context Exercise is a cornerstone of type 2 diabetes management, improving glycemic control, cardiovascular risk factors, and overall fitness.…
Summary: In adolescents with poorly controlled type 1 diabetes (T1D), improvements in glycemic control and reductions in methylglyoxal-derived hydroimidazolone (MG-HI)…
Clinical Context Cardiovascular disease remains the leading cause of death in type 2 diabetes, driven by diabetic dyslipidemia—a characteristic pattern…
Summary: In adults diagnosed with chronic high-altitude disease living at high elevation, hydrogen-rich water (HRW) supplementation for 60 days as…
Clinical Context Cardiac rehabilitation (CR) is a cornerstone of secondary prevention in coronary artery disease, reducing cardiovascular mortality by approximately…
Clinical Context Charcot neuroarthropathy (CN) is a devastating complication of peripheral neuropathy, most commonly occurring in diabetes. Progressive bone destruction,…
Clinical Context Gestational diabetes mellitus (GDM) affects 6-15% of pregnancies and is increasing in prevalence alongside the obesity epidemic. GDM…